Editorial

Cost-effectiveness of an FFR-guided strategy during STEMI – no rose without a thorn

EuroIntervention 2022;18:188-189. DOI: 10.4244/EIJ-E-22-00014

Suzanne Baron
Suzanne J. Baron1, MD, MSc
1. Lahey Hospital and Medical Center, Burlington, MA, USA
Fractional flow reserve (FFR) and other forms of physiological assessment of intermediate coronary artery stenoses have revolutionised how ischaemic heart disease is treated. Economic analyses evaluating the use of FFR to guide percutaneous coronary intervention in stable coronary artery disease (CAD) have demonstrated that FFR is cost effective when compared to an angiography-guided strategy1. Whether these economic benefits extend to a population of patients with multivessel CAD presenting with ST-elevation myocardial infarction (STEMI) has been unknown until now.

In this issue of EuroIntervention, Le Bras and colleagues report the results of a prespecified within-trial economic analysis of the FLOWER-MI ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Stop at the yellow light spot: in vivo detection of preclinical atherosclerosis

Latest news